Get started
Author

Nathalie Rohmann

Observed names: N Rohmann, Rohmann, Nathalie
ORCID: 0000-0001-9038-5845
Observed ORCID: 0000-0001-9038-5845
OpenAlex ID: A5081928632
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes
2022 · Lea Henneke, Kristina Schlicht, et al. · Gut Microbes · 164
PDF
Is human obesity an inflammatory disease of the hypothalamus?
2023 · Lena Sonnefeld, Nathalie Rohmann, et al. · European Journal of Endocrinology · 48
PDF
Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
2020 · Kristina Schlicht, Nathalie Rohmann, et al. · International Journal of Obesity · 38
PDF
Physical activity‐induced alterations of the gut microbiota are BMI dependent
2023 · Shrushti Shah, Chunlong Mu, et al. · The FASEB Journal · 35
PDF
Prediabetes and type 2 diabetes but not obesity are associated with alterations in bile acid related gut microbe-microbe and gut microbe-host community metabolism
2025 · Kristina Schlicht, Lea Pape, et al. · Gut Microbes · 26
Circulating sDPP-4 is Increased in Obesity and Insulin Resistance but Is Not Related to Systemic Metabolic Inflammation
2020 · Nathalie Rohmann, Kristina Schlicht, et al. · The Journal of Clinical Endocrinology & Metabolism · 25
PDF
Microbiota in Health and Disease—Potential Clinical Applications
2021 · Matthias Laudes, Corinna Geisler, et al. · Nutrients · 23
PDF
Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failure
2021 · Tim Hollstein, Kristina Schlicht, et al. · Scientific Reports · 22
PDF
Metabolic and lifestyle factors accelerate disease onset and alter gut microbiome in inflammatory non-communicable diseases
2024 · Nathalie Rohmann, Theresa Geese, et al. · BMC Medicine · 20
PDF
Cohort profile: the Food Chain Plus (FoCus) cohort
2022 · Corinna Geisler, Kristina Schlicht, et al. · European Journal of Epidemiology · 16
PDF
Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungs
2023 · Nathalie Rohmann, Paula Stürmer, et al. · Journal of Advanced Research · 15
Influence of dietary components on the gut microbiota of middle-aged adults: the gut-Mediterranean connection
2025 · Shrushti Shah, Chunlong Mu, et al. · BMC Microbiology · 14
PDF
Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection
2022 · Nathalie Rohmann, Paula Stürmer, et al. · Frontiers in Immunology · 11
PDF
Comprehensive evaluation of diabetes subtypes in a European cohort reveals stronger differences of lifestyle, education and psychosocial parameters compared to metabolic or inflammatory factors
2025 · Nathalie Rohmann, Johannes Epe, et al. · Cardiovascular Diabetology · 9
A Prospective Analysis of the Metyrapone Short Test Using Targeted and Untargeted Metabolomics
2023 · Anna Katharina Seoudy, Kristina Schlicht, et al. · Neuroendocrinology · 8
BMI, Alcohol Consumption and Gut Microbiome Species Richness Are Related to Structural and Functional Neurological Abnormalities
2021 · Corinna Geisler, Jil Pankoke, et al. · Nutrients · 8
PDF
Differential Effects of Obesity, Hyperlipidaemia, Dietary Intake and Physical Inactivity on Type I versus Type IV Allergies
2022 · Nathalie Rohmann, Liasita Munthe, et al. · Nutrients · 7
PDF
A Dietary Carbohydrate – Gut Parasutterella – Human Fatty Acid Biosynthesis metabolic axis in obesity and type 2 diabetes
2022 · Lea Henneke, Kristina Schlicht, et al. · Diabetologie und Stoffwechsel · 7
Dipeptidylpeptidase (DPP)-4 inhibitor therapy increases circulating levels of anti-inflammatory soluble frizzle receptor protein (sFRP)-5 which is decreased in severe COVID-19 disease
2022 · Juliane Brandes, Isabelle Zobel, et al. · Scientific Reports · 4
PDF
Weight loss impacts risky decisions in obesity
2024 · Beatrix Keweloh, Damiano Terenzi, et al. · Clinical Nutrition · 3
Correction: Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
2021 · Kristina Schlicht, Nathalie Rohmann, et al. · International Journal of Obesity · 2
PDF
Healthy lifestyle, daytime sleepiness, and gut microbiome composition are determinants of functional strength in humans: a cross-sectional study
2025 · Friederike Norkeweit, Kristina Schlicht, et al. · Scientific Reports · 1
PDF
Dipeptidylpeptidase (DPP)-4 inhibitor therapy increases circulating levels of anti-inflammatory soluble frizzle receptor protein (sFRP)-5 which is decreased in severe COVID-19 disease
2022 · Kristina Schlicht, Juliane Brandes, et al. · Diabetologie und Stoffwechsel · 1
Analysis code for: Pathway-restricted polygenic scores for energy-substrate metabolism and obesity – a systematic screen in the FoCus cohort
2026 · Hinz, Sophia, Geisler, Corinna, et al. · Zenodo (CERN European Organization for Nuclear Research)
Lifestyle, metabolic, and gut microbial determinants of hypertension onset according to metabolic dysfunction status: insights from the population-based FoCus study
2026 · Weixiao Wang, Aleksandra Joanna Czakyrowa, et al. · Research Square
PDF
Works count: 77
Citation count: 507
H-index: 12
I10-index: 13
Year
Topic
Type